CD279, Human (Camrelizumab biosimilar) Antibody from KMD BIOSCIENCE CO. LTD.

Search, find, compare suppliers for anti-CD279, Human (Camrelizumab biosimilar) antibody, protein, ELISA kits.

Edit 
Antigenic SpecificityCD279, Human (Camrelizumab biosimilar)
CloneCamrelizumab
Host SpeciesRecombinant
Reactive Specieshuman
IsotypeIgG4 kappa
Formatpurified
Size1mg, 5mg
Concentration1mg/ml
ApplicationsELISA, IHC, IF, IP, FCM, Block
Reviews / RatingsIf you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY.
DescriptionAnti-Human CD279 Recombinant Antibody (Camrelizumab). Camrelizumab (SHR-1210) (INN) is an anti-PD-1 immune checkpoint inhibitionitor that is being investigated for hepatocellular carcinoma and Hodgkin lymphoma. This drug is being developed by Jiangsu HengRui Medicine Co., Ltd. As of 2019, camrelizumab is undergoing Phase II/III trials.
Immunogenn/a
Other NamesAnti-CD279 Recombinant Antibody, Research Grade Camrelizumab, Anti-Human CD279 Recombinant Antibody(Camrelizumab), SHR-1210, Antibody Drug Analogues, Monoclonal Antibody, YR1436, Research Grade Biosimilars, Biosimilar Antibody
Gene, Accession #CAS: 1798286-48-2
Catalog #YR1436
Priceplease inquire
Order / More InfoCD279, Human (Camrelizumab biosimilar) Antibody from KMD BIOSCIENCE CO. LTD.
Product Specific Referencesn/a
KMD BIOSCIENCE CO. LTD.
KMD BIOSCIENCE CO. LTD.
KMD BIOSCIENCE CO. LTD.
FL-4, Building A5
International Enterprise Community
Tianjin CHINA
P: 400-621-6806

info@kmdbioscience.com
Sales: sales@kmdbiosci.com

https://www.kmdbioscience.com

Profile of KMD BIOSCIENCE CO. LTD.
Return to Antibodies

© 1980 - 2024 Linscott's Directory, Linscott's USA. All rights reserved.